Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert review of anti …, 2013 - Taylor & Francis
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management
JM Pogue, T Mann, KE Barber… - Expert review of anti …, 2013 - Taylor & Francis
Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized
patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A …
patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A …
Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic …
HJ Lee, PJ Bergen, JB Bulitta, B Tsuji… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Combination therapy may be required for multidrug-resistant (MDR) Acinetobacter
baumannii. This study systematically investigated bacterial killing and emergence of colistin …
baumannii. This study systematically investigated bacterial killing and emergence of colistin …
[HTML][HTML] The Acinetobacter baumannii group: a systemic review
H Zhang, J Zhang, L Qiao - World journal of emergency medicine, 2013 - ncbi.nlm.nih.gov
BACKGROUND: The Acinetobacter baumannii group, including Acinetobacter baumannii,
Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and …
Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and …
In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens
L Phee, M Hornsey, DW Wareham - European journal of clinical …, 2013 - Springer
The activity of colistin in combination with daptomycin was assessed using 30 Gram-
negative type strains and multidrug-resistant isolates with defined mechanisms of …
negative type strains and multidrug-resistant isolates with defined mechanisms of …
Is there really no benefit to combination therapy with colistin?
Evaluation of: Colistin and Rifampicin compared with colistin alone for the treatment of
serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter …
serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter …
Editorial Commentary: Rifampicin Plus Colistin in the Era of Extensively Drug-Resistant Acinetobacter baumannii Infections
TP Gauthier - Clinical infectious diseases, 2013 - academic.oup.com
The spread of antimicrobial resistance has left healthcare practitioners worldwide with few
therapeutic options for infections caused by multidrug-resistant organisms [1, 2]. Efforts such …
therapeutic options for infections caused by multidrug-resistant organisms [1, 2]. Efforts such …
抗鲍曼不动杆菌药物研究进展
刘坤锋， 吴洁， 顾觉奋 - 国外医药: 抗生素分册, 2013 - cqvip.com
鲍曼不动杆菌已经成为院内感染的主要病原体, 并且随着多重耐药鲍曼不动杆菌(MDRAB)
的增加, 对它的治疗已经受到重视. 本文着重介绍了针对多重耐药鲍曼不动杆菌的抗生素 …
的增加, 对它的治疗已经受到重视. 本文着重介绍了针对多重耐药鲍曼不动杆菌的抗生素 …
外科重症监护病房呼吸机相关性肺炎不恰当初始抗菌治疗的临床分析
瞿昌晶， 刘海龙， 郭旋， 俞申燕， 吴文美 - 中国医师进修杂志, 2013 - cqvip.com
目的探讨外科重症监护病房(SICU) 呼吸机相关性肺炎(VAP) 不恰当初始抗菌治疗的现状及其对
患者预后的影响. 方法对2012 年2 月至2013 年8 月SICU 发生VAP 患者的临床资料进行回顾性 …
患者预后的影响. 方法对2012 年2 月至2013 年8 月SICU 发生VAP 患者的临床资料进行回顾性 …
[PDF][PDF] Synergistic Activity of Colistin and
MR Acinetobacter - 2013 - researchgate.net
Pharmacokinetic/Pharmacodynamic Model In Vitro baumannii in an Multidrug-Resistant
Acinetobacter Rifampin Combination against Sy Page 1 Published Ahead of Print 28 May …
Acinetobacter Rifampin Combination against Sy Page 1 Published Ahead of Print 28 May …